Cadila Healthcare Share Price Gained More Than A Percent Intraday - Dollar Advisory & Financial Services

Breaking

Friday 30 June 2017

Cadila Healthcare Share Price Gained More Than A Percent Intraday

Cadila Healthcare share price gained more than a percent intraday after receiving approval from the US health regulator for drug that is used for obesity.

Zydus Cadila has received the final approval from the US Food and Drug Administration to market Phentermine hydrochloride orally disintegrating tablets.

The drug is used together with diet and exercise to treat obesity in people with risk factors such as high blood pressure, high cholesterol or diabetes.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

No comments:

Post a Comment